Tenaya Therapeutics (TNYA) Current Taxes (2023 - 2026)

Tenaya Therapeutics (TNYA) posted quarterly Current Taxes of $406000.0 for Q1 2026, up 46.57% quarter-over-quarter from $277000.0 in Q4 2025.

Tenaya Therapeutics (TNYA) Current Taxes (2023 - 2026) Analysis & Trends

Tenaya Therapeutics' Current Taxes history runs 4 years deep, the most recent figure standing at $406000.0 for Q1 2026.

In Q1 2026, Current Taxes changed N/A year-over-year to $406000.0; the TTM figure through Mar 2026 stood at $406000.0 (changed N/A YoY), while the FY2025 annual figure was $277000.0, down 20.4% from the prior year.
Current Taxes for Q1 2026 stood at $406000.0, up from $277000.0 in the prior quarter.
The five-year high for Current Taxes was $836000.0 in Q2 2024, with the low at $202000.0 in Q3 2024.
The 4-year median for Current Taxes is $314000.0 (2023), against an average of $391500.0.
The sharpest annual moves came in 2024 and 2025: Current Taxes rose 24.29% in 2024, then dropped 20.4% in 2025.
Tenaya Therapeutics' Current Taxes stood at $280000.0 in 2023, then advanced by 24.29% to $348000.0 in 2024, then decreased by 20.4% to $277000.0 in 2025, then surged by 46.57% to $406000.0 in 2026.
Business Quant data shows TNYA's Current Taxes at $406000.0 in Q1 2026, $277000.0 in Q4 2025, and $348000.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	49.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	76.32 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	76.36 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Tenaya Therapeutics	151.50 Mn	151.50 Mn	-	529,000.00

Download Data